Results 251 to 260 of about 114,887 (311)

Predicting optimal impact interventions in the post‐HPV vaccination world

International Journal of Cancer, Volume 158, Issue 9, Page 2262-2271, 1 May 2026.
Abstract Prophylactic vaccination is a powerful tool that changes exposure to infections and associated morbidity of preventable diseases. We discuss the impact of pneumococci and human papillomavirus (HPV) vaccination on the population biology of the two micro‐organisms and related public health effects.
Matti Lehtinen, Marc Lipsitch, Ville N. Pimenoff, Karin Sundström, Johannes Berkhof, Iacopo Baussano, Simopekka Vänskä, Joakim Dillner   +7 more
wiley   +1 more source

Race‐specific temporal trends of HPV‐related cancers in South Africa: An analysis of the South African National Cancer Registry, 2011–2022

International Journal of Cancer, Volume 158, Issue 9, Page 2283-2288, 1 May 2026.
What's new? Racial disparities in trends of human papillomavirus (HPV)–associated cancers in South Africa have received limited attention. Here, the authors examined cancer incidence rates among South Africans, with stratification by race and sex, for different timeframes across 2011–2022.
Adino T. Tsegaye, Sizeka A. Mashele, Jaimie Z. Shing, Judith Mwansa‐Kambafwile, Aimée R. Kreimer, Carole Metekoua, Meredith S. Shiels, Mazvita Muchengeti   +7 more
wiley   +1 more source

International Collaborative Study on Human Papillomavirus Analytical Thresholds for Sensitivity and Specificity in Cervical Screening

Journal of Medical Virology, Volume 98, Issue 5, May 2026.
ABSTRACT Human papillomavirus (HPV) assays vary regarding the minimum amount of virus they detect. We investigated analytical thresholds of HPV detection and cervical screening sensitivity and specificity. One hundred cervical intraepithelial neoplasia grade 2 or worse (CIN2+) cases and 200 matched population‐based controls were obtained at the Swedish
Emel Yilmaz, Gerald Laurence Murray, Prisha Balgovind, Suzanne Marie Garland, Rita Pereira, Davy Vanden Broeck, Nina Redzic, Jean‐Luc Prétet, Quentin Lepiller, Steffi Silling, Clementina Cocuzza, Marianna Martinelli, Allan Campbell, Conor Brown, Kate Cuschieri, Linzi Connor, Anja Oštrbenk, Mario Poljak, Murat Gultekin, Yalın Kılıç, Klara Miriam Elfström, Laila Sara Arroyo Mühr, Joakim Dillner   +22 more
wiley   +1 more source

Predicting Different Recurrence Risk in HNSCC Using Circulating Inflammatory and T‐Cell Biomarkers

The Laryngoscope, Volume 136, Issue 5, Page 2189-2198, May 2026.
ABSTRACT Objective Head and neck squamous cell carcinoma (HNSCC) lacks reliable prognostic circulating biomarkers, and the role of the immune system in its progression remains incompletely understood. This study aimed to evaluate the prognostic value of systemic inflammatory and immune biomarkers in surgically treated patients with primary oral cavity (
Riccardo Gili, Paola Lovino Camerino, Luca Lalli, Elisa Bellini, Chiara Tagliaferri, Filippo Bruno Lanza, Stefania Vecchio, Simone Caprioli, Giorgio Peretti, Lucia Del Mastro, Filippo Marchi   +10 more
wiley   +1 more source

Nonclassical MHC‐I Molecules: Emerging Therapeutic Targets in Next‐Generation Immunotherapy

MedComm, Volume 7, Issue 5, May 2026.
Immunotherapies dependent on classical MHC‐I molecules face significant challenges, including extreme polymorphism and frequent downregulation in pathological conditions. This review discusses how nonclassical MHC‐I molecules (HLA‐E, HLA‐F, HLA‐G, CD1, MR1) may potentially circumvent these limitations through restricted genetic diversity, stable ...
Wanlin He, Andrew J. McMichael
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Human papillomavirus infection

Disease-a-Month, 2016
Human papillomavirus (HPV) is a DNA virus that causes a variety of conditions including common warts, condyloma acuminata (anogenital warts), and multiple malignancies involving the squamous epithelium. HPV is a unique oncogenic infectious agent that causes cervical cancer, the second most common cancer in women worldwide.
Jack N, Hutter, Catherine F, Decker
openaire   +2 more sources

Human papillomavirus infection

Journal of the American Academy of Dermatology, 1989
Of porri, verucae, and eondylomata of the pudenda. There remains a fourth species of venereal disease to be added to those which we have already described, viz, warty excrescences of the genitals, which sometimes succeed impure coition, but for the most part follow other porky disorders that have been iU managed. Sometimes they wither of themselves and
openaire   +3 more sources

Human Papillomavirus Infections

Advances in Pediatrics, 1992
Though the existence of disease associated with HPV has been documented for centuries, it has been only within the past 2 decades that we have recognized the clinical diversity and significant morbidity and mortality associated with HPV infections.
openaire   +2 more sources

Human papillomavirus infection

Journal of the American Academy of Dermatology, 1990
The human papillomavirus, well known as the etiologic agent of warts, has recently received much attention in the medical literature for its association with various cancers. This article discusses the virology, epidemiology, pathogenesis, immunology, clinical manifestations, and therapy for human papillomavirus infection.
openaire   +2 more sources

Genital Human Papillomavirus Infections

Clinics in Laboratory Medicine, 1989
Genital human papillomavirus (HPV) infection is an increasingly common sexually transmitted disease that has been associated with carcinoma of the cervix. Genital warts are easily diagnosed by clinical criteria; however, the more prevalent subclinical infections generally require laboratory diagnosis.
J M, Douglas, B A, Werness
openaire   +2 more sources